GlassScriptPhysician profile
Sandra Blandon
NPI 1013905132
$8,000.54
in general payments reported to CMS, 2019-2025
21 companies · $1,724 in 2025
The $1,724 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $488 · 2022: $715 · 2023: $2,387 · 2024: $2,687 · 2025: $1,724.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,797.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,972.86 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $1,449.40 | 2022-2024 | Arexvy, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,022.39 | 2023-2025 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $619.07 | 2023-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Abbvie INC. | $541.20 | 2021-2023 | |
| Phathom Pharmaceuticals, INC. | $484.20 | 2024-2025 | Voquezna |
| Gilead Sciences, INC. | $471.41 | 2022-2024 | Vemlidy |
| Genentech USA, INC. | $293.96 | 2021-2025 | Xolair |
| Sage Therapeutics, LLC | $191.71 | 2023-2024 | |
| Inspire Medical Systems, INC. | $147.09 | 2025 | Inspire |
| Pfizer INC. | $135.39 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $127.02 | 2025 | Cobenfy |
| Calliditas Therapeutics US INC. | $125.00 | 2023 | Tarpeyo |
| Mylan Specialty L.P. | $109.41 | 2023 | Yupelri |
| Lilly USA, LLC | $96.15 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $63.80 | 2021-2022 | |
| Exact Sciences Corporation | $44.81 | 2024-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $37.26 | 2024-2025 | Gardasil 9, Capvaxive, Gardasil |
| Organon LLC | $24.26 | 2022 | |
| Corcept Therapeutics | $22.37 | 2025 | Korlym |
| Novo Nordisk INC | $21.78 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Blandon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.